Table 1.
Differential RNA expression and FDs between breast cancer tumors and benign tissues
| HERV-related RNA (mRNA/lncRNA) | FD | 95% CI, low | 95% CI, high | p value |
|---|---|---|---|---|
| Downregulated expression | ||||
| ERV3-1 | −1.75 | −2.77 | −1.10 | 0.03639 |
| ERVK-7 | −1.47 | −2.07 | −1.05 | 0.01015 |
| Upregulated expression | ||||
| ERVK13-1 | 2.30 | 1.55 | 3.40 | 0.00021 |
| Nonsignificant results | ||||
| ERVV-1 | 1.99 | −1.04 | 4.14 | 0.16550 |
| ERVE-4 | 1.30 | −1.16 | 1.95 | 0.47441 |
| ERVK11-1 | −1.24 | −2.18 | 1.42 | 0.66534 |
| HCP5 | 1.05 | 0.65 | 1.70 | 0.79749 |
Three endogenous controls (actin beta, IPO8, and RPLP0) were used for data normalization. FD, fold difference; CI, confidential interval.